go back

2-METHYL-3-HYDROXYBUTYRYL-CoA DEHYDROGENASE DEFICIENCY (HSD10)

2-METHYL-3-HYDROXYBUTYRYL-CoA DEHYDROGENASE DEFICIENCY (HSD10)
17-BETA-HYDROXYSTEROID DEHYDROGENASE X DEFICIENCY; HSD10 MITOCHONDRIAL DISEASE; HSD10MD
300438
OMIM = Online Mendelian Inheritance of Men
391417
3-hydroxyacyl-CoA dehydrogenase type-2
1.1.1.178, 1.1.1.35
Xp11.22
E72.8
very rare (<1:1000000)
X-linked dominant
mutation in the HSD17B10 gene
most patients are male, less severe phenotype in females
Clinical symptoms as well as the impressive lactic acidosis found in some patients may mimic a mitochondrial disease [Perez-Cerda C et al. 2005]
Laboratory findings   Tiglylglycine inc (urine)
    2-Ethylhydracrylic acid inc (urine)
    2-Methyl-3-hydroxybutyric acid inc (urine)
    Ketone bodies (urine) normal/inc (urine)
    L-Lactic acid inc (cerebrospinal fluid)
    L-Lactic acid inc (urine)
    L-Lactic acid inc (serum)
Symptoms    anemia
    basal ganglia, changes, lesions, calcifications (MRI, CT)
    behavior, hyperactive, restless
    cardiomyopathy
    cerebral atrophy
    chorea or athetosis
    dysarthria
    early death
    hearing defect, deafness
    hypotonia
    ketosis, ketoacidosis
    lactic acidosis
    mental retardation
    metabolic acidosis
    motor retardation
    MRI, brain, white matter abnormalities [-]
    nystagmus
    onset, childhood
    onset, infancy
    onset, neonatal
    optic atrophy
    periventricular white matter changes
    progressive neurologic defect
    retinopathy
    seizures
    sex: male > female
    speech development, delayed, abnormal
    tremor or twitching
    white matter changes, abnormalities